Iron management in nondialysis-dependent CKD

Area of Science:

• Nephrology
• Hematology

Background:

• Iron deficiency is prevalent in chronic kidney disease (CKD) patients, particularly those with anemia.
• While extensively studied in hemodialysis patients, iron treatment in nondialysis CKD remains less understood.
• Iron deficiency can impede erythropoiesis and reduce the efficacy of anemia management.

Purpose of the Study:

• To review the current understanding of iron deficiency diagnosis and treatment in nondialysis CKD patients.
• To highlight the differences between nondialysis and hemodialysis CKD populations regarding iron management.
• To identify gaps in current research and suggest directions for future evidence-based guidelines.

Main Methods:

• Literature review focusing on iron deficiency in nondialysis CKD.
• Analysis of diagnostic approaches, emphasizing clinical judgment over solely lab results.
• Evaluation of treatment strategies, including oral versus intravenous iron administration.

Main Results:

• Iron deficiency is common and hinders anemia treatment in nondialysis CKD.
• Clinical judgment is crucial for diagnosing iron deficiency due to limited data on iron testing interpretation.
• No clear advantage of intravenous over oral iron was demonstrated in this population.
• Oral iron therapy is a reasonable first-line option unless contraindicated or ineffective.

Conclusions:

• Iron deficiency management in nondialysis CKD requires careful diagnosis and consideration of blood loss.
• Oral iron is a practical treatment choice, but further research is essential.
• Evidence-based guidelines are needed to optimize iron therapy for this distinct patient group.